OptionsHouse

Options Trading News

December 18, 2012  Tue 3:47 AM CT

IMMU: SEE CHART GET CHAIN FIND STRATEGIES
A long-term bearish play is apparently betting that Immunomedics will revisit levels where the drug developer traded more than three years ago.

About 1,350 January 2014 2 puts were purchased for $0.35, optionMONSTER's Depth Charge system shows. The volume was above the strike's open interest of 831 contracts at the start of the session, indicating that this is fresh buying.

IMMU rose 1.36 percent yesterday, or $0.04, to close at $2.98, not far from its lows of the year. The biopharmaceutical company's shares have traded in a tight range all year, mostly between about $2.90 and $3.90.

The put buying wasn't tied to any stock trades identified by our systems yesterday, so it could be a straight bearish position looking for IMMU to fall roughly 45 percent by expiration in January 2014. The stock has not seen prices that low since May 2009. (See our Education section)

Total option volume in the name yesterday was more than double its daily average for the last month. Only 166 calls traded in the entire session, a reflection of the day's bearish sentiment.
Share this article with your friends


Related Stories

IMMU

Momentum bulls chase Immunomedics

April 26, 2016

The biopharmaceutical company has rocketed 63 percent in the last three months, and traders are betting that the uptrend will continue.

OptionsHouse

Premium Services

Education & Strategy

Market Level Making You Nervous, Huh? Part 3

In last week's article, we discussed how important the extra cash you save by using the Stock Replacement Strategy over buying the actual stock is! That extra cash in our account instead of being unnecessarily tied up in a stock position allows us to buy the puts we would need to protect our downside in the case of a major sell-off.

View more education articles »